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Abstract.  Physical interaction between human lym- 
phomas and murine bone marrow derived stromal 
cells were studied.  Nalm-6 pre-B cells adhered to 
BMS2 stromal cells and subsequently migrated be- 
neath them,  while Ramos Burkitt lymphoma cells, ad- 
hered but did not migrate.  Four mAbs were estab- 
lished against Nalm-6 cells, which were able to block 
initial adhesion of Nalm-6 cells.  Two of them were 
directed against the oe4 chain of VLA-4, and other two 
recognized the ~t chain of VLA integrins.  Therefore, 
the initial adhesion of Ramos and Nalm-6 cells to 
BMS2 was largely mediated by the VLA-4 integrin ex- 
pressed on lymphocytes. The corresponding ligand on 
stromal cells appears to be VCAM-1,  because antibod- 
ies against murine VCAM-1  blocked the adhesion. 
However, antibodies against the ot chain of VLA-4 
were not capable of blocking subsequent migration be- 
neath stromal cells. In contrast,  antibodies against the 
chain of VLA integrins  blocked the migration  be- 
neath stromal cells as well as the initial adhesion.  Be- 
cause a common B chain can be shared among inte- 
grins,  the role of other VLA integrins  in Nalm-6 cells 
migration  was investigated.  VLA-5 and VLA-6 as well 
as VLA-4 were expressed on Nalm-6 cells,  but not on 
Ramos cells. Additional blocking experiments revealed 
that VLA-4 and VLA-5 are likely to work in concert 
to mediate the migration of Nalm-6 cells beneath 
stromal cells. Thus, particular VLA integrins  appear 
to be responsible not only for lymphocyte adhesion 
but also for migration  with respect to stromal cells. 
These findings may have implications  for cell-cell in- 
teractions and directed migration of lymphocytes in 
bone marrow and other tissues. 
YMPrtOCVT~ progenitors grow and differentiate  in bone 
marrow, where the microenvironment  plays a crucial 
role in lymphopoiesis (10, 11). A  stromal  cell,  for 
example,  produces  a  number  of factors affecting  growth 
and differentiation  of lymphohemopoietic progenitor cells 
(11). Some factors such as Steel factor (30), or macrophage 
colony-stimulating  factor  (CSF-1)  ~ (27)  are  produced  in 
either membrane bound or soluble forms, both of which may 
have biological activities  (3, 27).  The close contact of lym- 
phohemopoietic progenitors with stromal cells could make 
growth factors, particularly  membrane bound ones, more 
accessible. 
We recently  identified  one,  very late  antigen-4  (VLA- 
4)/vascular cell adhesion molecule-1  (VCAM-1) cell adhe- 
sion pathway that may be critical for the interaction  between 
lymphocyte progenitors and stromal cells (14). These cell 
adhesion molecules (CAMs) are expressed in bone marrow 
and  mAb  treatment  detached  lymphoid  cells  from  the 
stromal layer in long term bone marrow cultures (15). How- 
1. Abbreviations used in this paper: CAM, cell adhesion molecules; CSE 
colony-stimulating  factor;  2-ME,  2-mercaptoethanol; VCAM,  vascular 
CAM; VLA, very late antigen. 
ever, this cell adhesion  pathway may not explain all the as- 
sociations  between  B  lymphocyte  progenitor  cells  and 
stromal cells. Many pre-B lymphocyte cell lines, after initial 
adhesion to  stromal  cells,  crawl  beneath them (31).  This 
phenomenon has been referred to as pseudoemperipolesis 
(7), and occurs with thymocyte (16), and B lymphocyte pro- 
genitors (31) as well as in mature lymphocytes (8) or granu- 
locytes (25) interaction  with endothelial  cells in culture.  It 
is possible that this striking in vitro phenomenon reflects mo- 
lecular  mechanisms  used  by  lymphocyte progenitors  to 
orientate themselves in bone marrow. Lymphocyte progeni- 
tors would not only associate with stromal cells, but migrate 
with respect to them as differentiation  proceeds (9). 
The present study has been focused on molecular mecha- 
nisms  underlying  pseudoemperipolesis,  the migration  be- 
neath stromal ceils. The human acute lymphocytic leukemia 
(ALL) cell of pre-B cell type, Nalm-6,  adhered to a murine 
stromal cell clone BMS2 and subsequently migrated beneath 
them.  Initial  adhesion  was largely  blocked by antibodies 
against VLA-4 or VCAM-1, but the subsequent migration be- 
neath  was not. 
A  cell  adhesion  screening  assay utilizing  Nalm-6  and 
BMS2 resulted in  four mAbs against  Nalm-6.  Two mAbs 
blocked the initial  adhesion but not subsequent migration. 
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VLA-4.  Two other  antibodies,  which blocked both initial 
adhesion and subsequent transmigration,  were against the 
~  chain of VLA-4. Because ~ chains can be shared among 
integrins, other VLA integrins could be involved in migra- 
tion beneath stromal cells. Combined addition of antibodies 
against VLA-4 and VLA-5 similarly blocked Nalm-6  cell 
migration as well as antibodies against ~, Our results sug- 
gest that VLA-4 and VLA-5 expressed on B lymphocyte pro- 
genitors  may  work  together  to  mediate  recognition  and 
orientation with respect to stromal cells. 
Materials and Methods 
Cells and Antibodies 
Human Burkitt lymphoma cell,  Ramos, and human erythroleukemia cell, 
K562 were obtained through JCRB (Japanese Cancer Research Resources 
Bank, Tokyo, Japan). Nalm-6 ceils were generously provided by Dr. P. W. 
Kincade (Oklahoma Medical Research Foundation, Oklahoma City, OK). 
BMS2 is a murine bone marrow-derived stromal cell clone (20). All cell 
lines were maintained in RPMI 1640 supplemented with 50 ~M 2-mercap- 
toethanol  (2-ME), antibiotics, and 10% FCS. 
BALB/c mice (Japan SLC Co., Shizuoka, Japan) were immunized with 
Nalm-6 ceils and then spleen cells were fused with Sp2/0 cells. Hybridoma 
supernatants were screened with a cell adhesion assay using Naim-6 cells 
and BMS2  cells.  Hybridoma  cells producing  blocking  antibodies  were 
cloned  by  limiting dilution  and reselected  by the same procedure.  Four 
mAbs were  established.  SG/73  and  SG/19 are  IgGl/K. SG/7  is IgA/K. 
SG/17 is IgG2a/~. TS1/22 (mouse anti-human  LFA-I: lymphocyte function 
associated  antigen-l)  hybridoma  cells  were  obtained  through  American 
Type Culture Collection (ATCC) (Rockville, MD). Rat mAbs against mu- 
rine VLA-4 (PSr2: IgG2b) and against murine VCAM-I (M/K-I: IgG0 were 
described previously (14). These antibodies were purified from aseitic fluid 
prepared from severe combined immunodeficient (SCID) mice. The culture 
supernatant of GoH3 (rat anti human VLA-6) (26) was donated from Dr. 
Arnoud  Sormenberg (Central  Laboratory  of the Netherlands Red Cross 
Blood Transfusion Service, Amsterdam, Netherlands). Mouse mAb against 
~l  chain  (4B4) (17) was a kind girl from Dr.  Chikao  Morimoto  (Dana 
Farber Cancer Institution, Boston, MA). Rat mAbs 13 and 16, which recog- 
nize integrin ~  and c~s, respectively (1), were provided by Dr. Kenneth M. 
Yamada (National Cancer Institute, Bethesda, MD). 
Fibronectin and CS-I Attachment Assay 
Human plasma fibronectin (5 t~g/rnl  in PBS; Gibco Laboratories, Grand Is- 
lands, NY) and CS-1 peptide-conjugated  rabbit  IgG (1.5 t~g/ml in PBS) 
which was prepared as described by Nojima et al. (17), were plated on 96- 
well plates (Immulon II, Dyaatech,  Alexandria, VA). After 2 h of incuba- 
tion  at  37~  the coated  wells were washed twice  with  PBS, and then 
blocked with 1% BSA in PBS for 2 h at 37~  Ramos cells (1  ￿  lOS) were 
preincubated with 10 ~g/ml of the indicated mAbs in serum-free medium 
for 30 min at 37~  and then transferred  to 96-weU plates coated  with 
fibronectin, CS-I-lgG, or BSA. After 1 h of  incubation at 37~  nonadherent 
cells were removed by addition and removal of prewarmed PBS two times. 
The number of residual cells bound to the wells was measured by adding 
100/~1 of 0.5 mg/mi MTT(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra- 
zolium bromide)  (Sigma Chemical  Co.,  St.  Louis,  MO)  in serum-free 
medium and incubating for 1 h at 37~  The formazan precipitate formed 
was dissolved in 200 t~l of 0.4 N HCI in isopropanol and OD was measured 
at 560 nm on a plate reader. Percent adherence was calculated by the follow- 
ing formula:  % adherence  =  (ODst0 of experimental wells  -  ODsto of 
BSA-coated welIs)/(ODs~o  of unwashed wells -  ODsto of unwashed wells 
-  OD56o of BSA-coated wells)  x  100. 
Cell Adhesion Assay 
Cell lines were radiolabeled by incubating 5 x  107 celts/ml in saline with 
20% FCS and 100 ~Ci of Na2StCrO4 (Amersham Japan, Tokyo, Japan) for 
2 h at 37~  and then washed three times in prewarmed complete medium 
(10% FCS RPMI 1640). The BMS2 stromal cell clone was plated in 24-well 
plates (Becton Dickinson Labware, Lincoln Park, NJ) at 3 ￿  104 cells/weU 
and allowed to grow overnight before the adhesion assay. The labeled cells 
(1  x  10S/well) were added to the stromal layer and incubated 30 rain at 
37~  The unbound  cells were  removed by three cycles of washing in 
prewarmed  complete  medium.  Before  each  aspiration,  plates  were 
vigorously agitated on a Vortex mixer to which a plate adaptor  was at- 
tached. Bound cells were lysed with 0.1 N NaOH, 0.1% Triton X-100 and 
the StCr counted with a gamma counter (Hewlett Packard Co., Palo Alto, 
CA). Percentages of bound cells were determined by the formula: percent 
bound =  ([epm from bound cells] =  [input cell associated cpm -  sponta- 
neously released cpm])  ￿  100. Antibodies (10 #g/nil) were added at the 
same time as the SlCr-labeled lymphoma cells. 
Cell Surface Biotinylation and Iramunoprecipitation 
Cells were surface labeled by a sulfosuccinimidobiotin (Sulfo-NHS-biotin) 
(Pierce Chemical Co., Rockford, IL) procedure  (14). Briefly, after three 
washes in HBSS, cells were suspended in saline with 0.1 N Hepes, pH 8.0 
(50 x  106 cells/mi). Sulfo-NHS-biotin was dissolved in a small amount of 
saline and added to cell suspensions such that the final concentration of 
sulfo-NHS-biotin was 0.1 mg/ml. After a 40-rain incubation at room tem- 
perature with occasional shaking, cells were washed three times with chilled 
RPMI 1640. The cell lysates were prepared (50  ￿  106 cells/ml) in a lysis 
buffer containing 50 mM Tris-HCl (pH Z5),  150 mM NaCI,  1%  Triton 
X-100, 50 mM iodoacetamide, 2 mM MgC12, 2 mM CaCI2, and 0.1% so- 
dium azide. Soybean trypsin inhibitor (i0 ~g/rnl), and PMSF (I mM) were 
added  as  protease  inhibitors.  After  centrifugation,  the  lysates  were 
precleared twice with 50/~1 of Sepharose 4B conjugated with normal goat 
serum, and then immunoprecipitated with a mAb bound to goat anti-mouse 
IgG conjugated Sepharose 4B (Zymed Laboratories, San Francisco, CA) for 
2 h at 40C with rotation. Goat anti-rat IgG Sepharose 4B was used for mAb 
13. After washing three times in the lysis buffer, the bound proteins were 
released by boiling for 5 min in a sample buffer containing 0.125 M Tris- 
HC1 (pH 6.8), 2% SDS, and 10% glycerol without 2-ME. SDS-PAGE  was 
carried out as described (14). 
After electrophoresis, the gels were equilibrated for 30 rain in a transfer 
buffer (25 mM Tris, 192 mM glycine, and 20% methanol) and proteins were 
electrophoretically blotted onto nitrocellulose membranes. The membranes 
were soaked for 1 h in PBS containing t0% BSA, 0.05% Tween 20, and 
0.1% thimerosal,  and followed by a 60-min  incubation with 0.1% HRP- 
conjugated avidin (Bio-Rad Laboratories,  Richmond, CA),  1% BSA, and 
0.05% Tween 20. After washing in PBS with 0.05% Tween 20, biotinylated 
proteins were visualized with PBS containing 0.6 mg/rnl 4-chloro-l-naphthol, 
0.003% hydrogen peroxide, and 20% methanol. 
Immunofluorescence A nalyses 
Ceils were incubated for 20 rain on ice with antibodies. This was followed 
by two washes with RPMI 1640 supplemented with 3% FCS and 0.1% so- 
dium azide, and incubated with FITC-labeled second reagents. Propidium 
iodide was added during the second incubation to detect dead cells. Labeled 
cells were then analyzed on a FAC-Scan  (FAC-scan is a registered trademark 
of Becton  Dickinson Co.,  Mountain View, CA). FITC conjugated goat 
anti-mouse IgG+A+M  (Zymed  Laboratories,  San Francisco,  CA) was 
used as an second reagent for mouse antibodies, FITC conjugated MAR18.5 
(mAb against rat K  chain) for rat mAbs, or FITC-labeled avidin (Organon 
Teknika Co.,  West Chester,  PA) for biotinylated antibodies.  For cross- 
blocking experiments, ceils were preincubated with saturtion amounts of 
unlabeled mouse antibodies for 20 rain, washed once, and then stained with 
either biotinylated antibodies (SG/7, SG/19, SG/17) or a rat antibody. FITC 
labeled avidin was used for biotinylated mABs, or FITC-labeled MAR18.5 
for a rat mAb. 
Migration Assay 
BMS2 cells were plated in a 24-well plate at 3  ￿  104 cells/well,  and al- 
lowed to grow for 2 d before use in migration assays. Lymphoid ceil lines 
(2  ￿  lOS/well)  were added to adherent cell layers, followed by overnight 
incubation (18 h), and then inspected by inverted phase contrast microscopy 
(Olympus, Tokyo, Japan), and photographed.  For cross section of stromal 
cell monolayer culture, BMS2 cells xvere plated in cell culture insert with 
which Cyclopore membrane (9-mm diana  and 3-t~m  pore size) (Falcon, Lin- 
coln Park,  NJ) was attached.  After overnight culture with Nalm-6 ceils, 
cyclopore membrane was removed from plastic, fixed in 6% formaldehyde 
in 0.1 M phosphate buffer (pH 7.3), embedded in paraffin. The section was 
stained with Toluidin blue. 
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Nalra-6 Cells Migrate beneath Stromal Cells 
after Adhesion 
Some cell adhesion pathways are conserved between human 
and mice such that a human lymphoid cell line can adhere 
to a murine stromal cell line. This was the case with two hu- 
man B lineage cell tumors, Ramos and Nalm-6, which read- 
ily attached to murine endothelial cell lines (15).  This was 
largely mediated by the VLA-4/VCAM-I cell adhesion path- 
way, because it was extensively blocked by both anti-VLA-4 
and anti-VCAM-1  mAbs (15).  The present study used a mu- 
rine bone marrow-derived stromal cell clone BMS2, instead 
of endothelial cell lines. Both Ramos and Nalm-6 cells ad- 
hered to BMS2.  Nalm-6 cells appeared,  however, distinct 
from Ramos cells by a  phase contrast microscopy (Fig.  1). 
While Ramos cell remained refractile, Nalm-6 cells turned 
dark in several hours.  This phenomenon has already been 
described  with thymocytes (16),  B  lymphocyte precursors 
(31),  mature T  lymphocytes (8), and neutrophilic granulo- 
cytes  (25).  These  reports  showed  that  dark  appearance 
reflected  crawling  beneath  stromal  cells  or  beneath  en- 
dothelial cells. This was referred to as pseudoemperipolesis 
(7).  The interaction between Nalm-6 cells and BMS2 cell 
looked like pseudoemperipolesis. To confirm this, cross sec- 
tion was carried out. Indeed, Nalm-6 cells migrated beneath 
stromal cell (Fig.  1 c). Moreover, dark cells appeared in the 
same focal plane as stromal cells, while refractile cells out 
of focus (data not shown), as is shown in neutrophilic granu- 
locytes (25). These results showed that Nalm-6 cells crawled 
beneath stromal cells after initial adhesion, and turned dark 
under a phase contrast microscopy. Turning to the dark ap- 
pearance would reflect the processes following initial adhe- 
sion, or migration beneath stromal cells. 
Although  initial adhesion was significantly blocked with 
Figure 1.  Adhesion of human B lin- 
eage cell tumors to murine  stromal 
cells.  Ramos cells  (a)  and  Nalm-6 
cells  (b)  were  inoculated  onto the 
BMS2  monolayer  prepared  in  24- 
well microplates, cultured overnight 
and photographed.  A  cross  section 
of BMS2 monolayer was shown in c. 
BMS2  stromal  cell monolayer  (St) 
was formed  above filter membrane 
(Mere),  and  several  Nalm-6  lym- 
phoma  cells  (Lyre) were  observed 
between them. Bar, 50 #m. 
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Figure 2. New mAbs to Nalm-6 cells inhibited Ramos cell adhesion 
to stromal cells.  Ramos cells were 5~Cr labeled,  and used in the 
cell  adhesion  assay as  described  in the Materials  and Methods. 
mAbs (10/zg/ml) to LFA-1 (TS1/22), murine VCAM-1 (M/K-l), mu- 
rine  VLA-4 (PS/2) along  with SG series  antibodies  were added 
simultaneously with Ramos cells. The values are presented as the 
means  -/- SD for quadruplicate  wells. 
antibodies against VLA-4 or VCAM-1 (15), subsequent pseu- 
doemperipolesis was not affected by these reagents (data not 
shown). Therefore other molecules could be involved in this 
phenomenon.  To  understand  the  molecular  mechanism, 
mAbs were prepared against Nalm-6 cells. 
Antibodies Which Block Lymphocyte Adhesion to and 
Migration Beneath Stromal Cells 
The cell adhesion system using Nalm-6 and BMS2 cells was 
used  for  screening,  and  selection  of  four  mAbs  which 
blocked initial adhesion of Nalm-6 cell to BMS2. The effect 
of these antibodies on initial adhesion is shown in Fig.  2. 
Ramos cell adhesion to BMS2 was used instead of Nalm-6 
ceils, because the results are clearer due to the lack of subse- 
quent migration. Similar results were obtained with Nalm-6 
cells as in the previous report (15). This adhesion was mostly 
blocked  by  anti-murine  VLA-4  antibody  PS/2,  or  anti- 
VCAM-1  antibody M/K-1.  As shown previously (15),  PS/2 
is crossreactive with human VLA-4. All SG series antibodies 
except SG/17 completely blocked this VLA-4/VCAM-I-de- 
pendent adhesion. VLA-4 is known to bind to fibronectin (5, 
29), in addition to VCAM-1.  As shown in Fig. 3, Ramos cells 
also adhered to the CS-1 portion of fibronectin in a VLA-4 
dependent manner. All of the SG series of monoclonal anti- 
bodies  clearly  blocked  Ramos  cell  adhesion  to  intact 
fibronectin or a CS-I-IgG fragment (Fig.  3).  These results 
suggested that the SG series antibodies may be reactive with 
VLA-4 integrin. 
The effects of SG series antibodies on migration beneath 
stromal cells were then investigated. Nalm-6 cells were inoc- 
ulated onto  BMS2  cells together with antibodies,  and in- 
cubated overnight. As shown in Fig. 4, both SG/7 and SG/19 
completely  kept  Nalm-6  cells  from  turning  dark,  while 
SG/17 and SG/73 could not. Nalm-6 cells did not migrate in 
the presence of SG/7  or SG/19.  This result discriminated 
SG/17 and SG/73,  from SG/7 and SG/19. 
Immunochemical and Flow Cytometric 
Characterization of Molecules Recognized 
by SG Antibodies 
For further characterization of the SG series antibodies, im- 
munoprecipitations  were  carried  out.  Three  antibodies 
(SG/7, SG/17, and SG/19) precipitated similar sized peptides 
from Ramos cells. The approximate sizes of these peptides 
were 110 and 140 kD under nonreducing conditions (Fig. 5 
A), and 130 and 150 kD under reducing conditions (data not 
shown).  SG/73 precipitated similar sized molecules as the 
other three antibodies, but the precipitated bands were not 
as distinct (data not shown). The epitope it recognizes may 
be labile on a solubilized molecule. The sizes of these two 
peptides are compatible with those known for VLA-4 (6). 
We  next  analyzed  the  SG  series  antibodies  by  immuno- 
fluorescence on K562 cells,  which express VLA-5 but not 
VLA-4 (data not shown). Neither SG/17 nor SG/73 stained 
K562 cells whereas SG/7 and SG/19 did (data not shown). 
These two antibodies were used for immunoprecipitation, 
and results are shown in Fig. 5 B. SG/7 and SG/19 precipi- 
tated similar sized molecules from K562 cells. The approxi- 
mate sizes were 110 and 140 kDa under nonreducing condi- 
tions, and 130 kDa when reduced (data not shown). These 
immunoprecipitation  results  were  very  similar  to  those 
reported for VLA-5 (1). As expected, SG/17 did not precipi- 
tate any molecule from K562 cells (data not shown). SG/17 
and SG/73  may be directed against the a  chain of VLA-4 
whereas SG/7 and SG/19 may recognize the common ~ chain 
of VLA integrins. 
Cross-blocking experiments were carried out to confirm 
the specificities of the SG series antibodies. The binding of 
PS/2 antibody was clearly blocked by pretreatment of Nalm- 
6 cells with the SG/73 antibody (data not shown). SG/73 and 
PS/2 antibodies may therefore recognize a shared or closely 
related  epitope  on  the  a  chain  of  VLA-4.  In  contrast, 
pretreatment with SG/17,  SG/7, or SG/19 antibodies did not 
block the binding of PS/2 to Nalm-6 cells.  SG/17 blocked 
VLA-4-dependent  Ramos  cell  adhesion  to  VCAM-1  and 
fibronectin (Figs.  2  and  3),  and precipitated similar sized 
molecules to VLA-4 (Fig. 5 A). Furthermore, SG/17 did not 
stain K562 cells. These results strongly supported the idea 
that SG/17 as well as SG/73 are directed against the ct chain 
of VLA-4. The finding that SG/17 did not block binding of 
PS/2 to Nalm-6 cells may be due to that the epitope recog- 
nized by SG/17 is distinct from that seen by SG/73 or PS/2 
antibodies. 
More detailed studies were then done with the SG/7 and 
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blocked Ramos cells adhesion 
to  fibronectin  or  CSI-IgG. 
Ramos cells were used in the 
cell  attachment  assay as de- 
scribed  in  the  Materials  and 
Methods.  A  mAb against B~ 
chain  (4B4)  was used  along 
with  SG  series  antibodies. 
The  results  are  presented  as 
the means +  SD for triplicate 
determinations. 
SG/19 antibodies,  mAb 13,  which was previously shown to 
be reactive with the Bt chain of VLA integrins (1), was used 
for immunoprecipitation  and epitope analysis.  As shown in 
Fig. 5 C, mAb 13 precipitated similar sized molecules to that 
recognized by SG/7. The SG/7 blocked rnAb 13's binding to 
Nalm-6 cells. A reciprocal experiment is the binding of SG/7 
to Nalm-6, and this was also blocked by mAb  13  (Fig.  6). 
SG/19 precipitated  similar sized molecules  from Ramos or 
l~gure 4. Nalm-6 cell migration beneath stromal cells was blocked by SG/7 or SG/19 but not by SG/73. Nalm-6 cells were added to the 
BMS2 monolayer with SG series mAbs (10 t~g/ml). After overnight culture, cells were inspected by phase contrast microscopy. (a) Without 
antibody; (b) SG/73;  (c) SG/7;  (d) SG/19.  SG/17 had no effect on Nalm-6 migration (data not shown). Bar, 50/~m. 
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surface biotin-labeled  materials from 
Ramos and K562 cells with SG series 
antibodies and mAb 13. Immunopre- 
cipitation  was  carried  out  as  de- 
scribed in  Materials and  Methods. 
Cell lysates from Ramos (lanes 1-3, 
6  and  7)  or K562  (lanes 4  and 5) 
were precleared and applied to beads 
which were conjugated with either 
SG/7 (lanes 1, 4, and 6), SG/17 (lane 
2), SG/19 (lanes 2 and 4), or 13 (lane 
7). Bound proteins were resolved on 
8.2%  SDS-PAGE under nonreduced 
conditions. 
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Figure 6. Cross-blocking analysis of 
SG/7 antibody with mAb 13. Nalm-6 
cells  were stained with 13 (left) or bi- 
otinylated SG/7 (right). Upper pan- 
els  show  control  staining  without 
pretreatment.  Hatched  lines  show 
staining  with  second  reagent  only 
(fluoresceinated mouse anti-rat kappa 
antibody for mAb 13, and fluorescei- 
nated avidin for SG/7). Lower panels 
show staining profiles with pretreat- 
ment of either SG/7, SG/17, or 13 as 
indicated. 
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blocked  13's  binding  to  Nalm-6  cells  (data  not  shown). 
Moreover,  SG/7  and  SG/19  efficiently crossblocked  each 
other's binding (data not shown),  indicating that epitopes 
recognized by them are  physically very close.  SG/7  and 
SG/19 must therefore be reactive with the ~i~ component of 
VLA integrins. SG/7 however could be discriminated from 
SG/19 in that SG/7 recognized a divalent cation dependent 
epitope on the ~  chain of integrins (K.  Miyake and M. 
Kimoto, manuscript in'preparation). Moreover the band of 
o~ chain is always more faint than that of #  chain (Fig. 5). 
This antibody might disrupt an association of the two chains. 
In summary, the newly established mAbs recognize the c~ 
chain (SG/17, SG/19) and ~ chain (SG/7, SG/19) of  the VLA-4 
molecule. 
VLA-4 and VLA-5 Are Required for Nalm-6 Cell 
Migration beneath Stromal Cells 
The  crawling of Nalm-6  cells beneath  stromal cells  was 
affected by anti-~t antibodies but not by anti-c~  antibodies 
(Fig. 4). This suggested that VLA integrins other than VLA-4 
was involved in this phenomenon, because the/~ chain is 
shared among VLA integrins (6, 23). Therefore the expres- 
sion of VLA integrins on Nalm-6 cells was studied. Nalm-6 
cells expressed VLA-4, -5, -6 (Fig. 7) but not VLA-1, -2, -3 
(data not shown). Ramos cells expressed VLA-4 and VLA-3 
but not VLA-1, -2, -5, or -6 (Fig. 7 and data not shown). The 
expression of VLA-5 and VLA-6 may explain the migration 
beneath stromal cells because Nalm-6 cells express these in- 
tegrins and migrate, but Ramos cells do not express these in- 
tegrins and do not migrate. The blocking effect of antibodies 
against VLA-4, -5, and -6 were investigated on Nalm-6 cell 
migration beneath stromal cells. The results are shown in 
Fig. 8. Any single antibody against VLA-4, -5, or -6 did not 
block Nalm-6 cell migration when used alone (Fig. 8, b-d). 
Only the combined addition of  the antibodies against VLA-4 
and VLA-5 had a similar blocking effect as antibodies against 
Bt chain. Other combinations, which included an antibody 
against VLA-6, had no effect (Fig. 8, land g). Nalm-6 cells 
are likely to use both VLA-4 and VLA-5 in concert for at- 
tachment to and migration beneath stromal cells. To examine 
the involvement of VCAM-1, an antibody against VCAM-1 
was added alone or together with an antibody against VLA-5, 
but the migration was not blocked (data not shown). 
Discussion 
Cell surface molecules were implicated in the migration of 
a  pre-B cell line,  Nalm-6,  beneath a  murine stromal cell 
BMS2.  Nalm-6  cells  adhered to  BMS2  cells  and subse- 
quently crawled beneath. Ramos cells, in contrast, did not 
migrate beneath but remained attached to stromal cell sur- 
face. Four mAbs were established, which could block Nalm- 
6 cell adhesion to BMS2. All these antibodies blocked VLA- 
4-dependent  adhesion  of  Ramos  cells  to  VCAM-1 and 
fibronectin. Two of them blocked Nalm-6 cell migration be- 
neath stromal ceils. Immunochemical and flow cytometric 
analyses revealed that these two antibodies were directed 
against the ~1 chain of integrins, and two other antibodies 
were reactive with the c~ chain of VLA-4. The expression of 
other VLA integrins were studied, because the/~1 chain is 
shared with other VLA integrins (6, 23).  Nalm-6 cells, in- 
deed,  expressed  VLA-5  and  VLA-6  as  well  as  VLA-4, 
whereas Ramos cells expressed VLA-4 but not VLA-5 or 
VLA-6.  The  combined  treatment  with antibodies  against 
VLA-4 and VLA-5 kept Nalm-6 cells from crawling beneath 
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Figure 7. Differential patterns of expression of VLA-4, 5, 6 integrins on Ramos cells and Nalm-6 cells. Rarnos cells and Nalm-6 cells 
were stained with 13 (anti-flz chain), SG/73 (anti-VLA-4), 16 (anti-VLA-5), or GoH3 (anti-VLA-6). Control profiles were stained with 
second reagent only and shown as hatched line. 
Miyake et al. Integrin Requirement in Lymphoma Cells Migration  659 Figure 8. Combined treatment with antibodies against VLA-4 and VLA-5 blocked Nalm-6 cells migration beneath stromal cells. Nalm-6 
cells were inoculated onto BMS2 monolayers with various antibodies (10 #g/ml). The culture supcrnatant was used for GoH3. Photographs 
were taken by phase contrast microscopy after over-night culture. (a) Without antibody; (b) anti-VLA-4 antibody (SG/73); (c) anti-VLA-5 
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tion with anti-VLA-4 or VLA-5 did not block the migration. 
Therefore VLA-4 and VLA-5 are likely to be employed in 
concert for Nalm-6 migration beneath stromal cells. The ab- 
sence of VLA-5 on Ramos cells may explain the reason why 
Ramos cells did not migrate beneath stromal cells. 
One of the important questions to be asked is the ligand(s) 
on stromal cells for VLA-4 and -5 during Nalm-6 cell migra- 
tion. The migration of Nalm-6 cells was not blocked with an 
antibody against VCAM-1 alone or together with an antibody 
against VLA-5. Therefore other molecules are likely to work 
during Nalm-6  cell migration as a  ligand for VLA-4,  al- 
though the involvement of VCAM-1 during migration is not 
excluded yet. Fibronectin would be the first candidate, be- 
cause VLA-4 as well as VLA-5 is known to be a receptor 
for fibronectin (6, 23). VLA-4 binds to the CS-1 portion of 
alternatively spliced fibronectin (5, 29), and VLA-5 binds to 
fibronectin in a  RGD peptide dependent manner (6,  23). 
Many studies reported that progenitors of erythroid or lym- 
phoid lineage attached to fibronectin but mature erythro- 
cytes or lymphocytes did not (2, 4, 13, 19, 28). For example, 
B220  § surface t~- cells from bone marrow avidly attached 
to fibronectin, whereas B220  § surface #§  cells from bone 
marrow did not (13). The expression of VLA-4 and/or VLA-5 
would explain these changes of affinity for fibronectin as is 
shown in erythrobtastic precursor cells (22)  or lymphoid 
precursor cells (24).  The affinity for fibronectin by either 
VLA-4 or VLA-5 alone may not be enough for migration be- 
neath stromal cells, because addition of antibody against ei- 
ther VLA-4 or VLA-5 could not completely inhibit migra- 
tion. Higher affinity for fibronectin achieved through VLA-4 
and VLA-5 could be needed for Nalm-6 cell migration. It is 
interesting in this context to note that fibronectin secretion 
and matrix assembly are polarized to the basolateral surface 
of endothelial cells (12). This might be the case with stromal 
cells. Nalm-6 cell migration might be guided by a gradient 
of fibronectin concentration from the apical to basal surface 
of stromal cells. Treatment with anti-fibronectin antibodies 
or peptides might be informative for further studies. 
B lineage cells may regulate their migratory properties 
with maturation by controlling the expression or affinity of 
cell adhesion molecules. The present study compared human 
B cell lymphoma and pre-B ALL. The former just adheres 
to murine stromal cells, and expresses VLA-4 but not VLA-5. 
The latter, which expresses both VLA-4 and VLA-5, not only 
adheres but  subsequently migrates beneath  stromal cells. 
This difference may reflect maturation states of pre-B and B 
lymphocytes, because the VLA-5 integrin is reported to be 
expressed on CD10 § B lymphocyte precursors in bone mar- 
row but not on mature CD20  § B lymphocytes in peripheral 
blood (24). VLA-4 remains expressed on mature B lympho- 
cytes but in lower amount than that on B lymphocyte  precur- 
sors in bone marrow.  Resident B  lymphocytes from lym- 
phoid organs including tonsils and peripheral lymph nodes 
express  less  VLA-4 than B  lymphocytes from peripheral 
blood (21). 
C-kit has been reported to be the receptor for Steel factor 
and to transduce growth  and/or differentiation signal  on 
hemopoietic progenitor cells  (reviewed in 30).  The c-kit 
positive cells in human bone marrow or fetal liver are highly 
enriched in progenitor cells of the erythroid or myeloid lin- 
eage, and express both VLA-4 and VLA-5,  whereas c-kit 
negative cells in bone marrow express VLA-4 but not VLA-5 
(18). Neither erythrocytes nor granulocytes in the circulation 
express  VLA integrins  (6).  VLA  integrin expression  on 
erythroid or myeloid lineage cells may change with their 
maturation sequentially, namely from VLA-4 and -5 posi- 
tive, through VLA-4 alone positive, and then to no VLA 
integrins. Steel factor, the ligand for c-kit, has a membrane 
bound form as well as a soluble form, and the former is sug- 
gested to be more important for physiologic roles in vivo 
than the latter (3). Progenitor ceils might need cell adhesion 
molecules for receiving efficient stimulation from membrane 
bound growth factors. In this context, VLA-4 and VLA-5 
may bring progenitor cells in tight association with stromal 
cells. As maturation proceeds, VLA-4 and VLA-5 may de- 
crease in their expression on progenitor cells. It will be in- 
teresting  to  determine the  signals  required  for changing 
affinities and/or expression of these integrins. 
While  studying physical  interactions  between  lympho- 
cytes and stromal cells, an ideal situation was found to dis- 
criminate between adhesion alone versus adhesion of lym- 
phocytes followed by transmigration beneath stromal cells in 
culture. One human pre-B ALL cell line, Nalm-6, attached 
to and crawled beneath a monolayer  of stromal cells whereas 
a more mature B cell lymphoma, Ramos, only attached to 
the upper surface, mAbs were prepared which blocked these 
events. Immunochemical and flow cytometric analyses were 
performed to determine which adhesion molecules were ex- 
pressed and which ones were responsible for adhesion and 
transmigration. Initial adhesion to the stromal cell surface 
was largely dependent on VLA-4 expressed by the lymphoid 
cells and its recognition of VCAM-1 on the stromal cells. 
However, this receptor-ligand pair was not sufficient  for sub- 
sequent migration beneath stromal cells. The latter phenom- 
enon was dependent on the concerted action of VLA-4 and 
VLA-5 integrins. These fndings may have implications for 
cell-cell interactions necessary for lymphocyte formation in 
bone marrow and directed migration of lymphocytes in other 
tissues. 
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